These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10617325)

  • 21. Demonstration of a pallido-nigral projection innervating dopaminergic neurons.
    Hattori T; Fibiger HC; McGeer PL
    J Comp Neurol; 1975 Aug; 162(4):487-504. PubMed ID: 50334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance P in the human brain.
    Mai JK; Stephens PH; Hopf A; Cuello AC
    Neuroscience; 1986 Mar; 17(3):709-39. PubMed ID: 2422595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders.
    Goto S; Hirano A; Rojas-Corona RR
    Acta Neuropathol; 1989; 78(5):543-50. PubMed ID: 2479214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of substance P, somatostatin, and neurotensin levels in aging in the rat and human central nervous system.
    Buck SH; Deshmukh PP; Burks TF; Yamamura HI
    Neurobiol Aging; 1981; 2(4):257-64. PubMed ID: 6174878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison analysis of distributions of tyrosine hydroxylase, calmodulin and calcium/calmodulin-dependent protein kinase II in a triple stained slice of rat brain.
    Sutoo D; Akiyama K; Yabe K
    Brain Res; 2002 Apr; 933(1):1-11. PubMed ID: 11929630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct projections from the central amygdaloid nucleus to the globus pallidus and substantia nigra in the cat.
    Shinonaga Y; Takada M; Mizuno N
    Neuroscience; 1992 Dec; 51(3):691-703. PubMed ID: 1283209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The morphology of substance P in the human brain as determined by an immuno-histo-fluorescence study].
    Constantinidis J; Taban C; Guntern R; Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 127(2):323-55. PubMed ID: 6169143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of GABA-immunoreactive neurons in the basal ganglia of the squirrel monkey (Saimiri sciureus).
    Smith Y; Parent A; Seguela P; Descarries L
    J Comp Neurol; 1987 May; 259(1):50-64. PubMed ID: 3294929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efferent connections of the caudate nucleus, including cortical projections of the striatum and other basal ganglia: an autoradiographic and horseradish peroxidase investigation in the cat.
    Royce GJ; Laine EJ
    J Comp Neurol; 1984 Jun; 226(1):28-49. PubMed ID: 6736295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anterior to posterior variations in the concentration of somatostatin-like immunoreactivity in human basal ganglia.
    Davies P; Josef J; Thompson A
    Brain Res Bull; 1981 Oct; 7(4):365-8. PubMed ID: 6117352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative mapping analyzer for determining the distribution of neurochemicals in the human brain.
    Sutoo D; Akiyama K; Yabe K
    J Neurosci Methods; 1998 Dec; 85(2):161-73. PubMed ID: 9874152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution, and morphology of cell death.
    Stefanis L; Burke RE
    Neuroscience; 1996 Oct; 74(4):997-1008. PubMed ID: 8895868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
    Grafe MR; Forno LS; Eng LF
    J Neuropathol Exp Neurol; 1985 Jan; 44(1):47-59. PubMed ID: 2578185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal substance P cell clusters coincide with the high density terminal zones of the discontinuous nigrostriatal dopaminergic projection system in the cat: a study by combined immunohistochemistry and autoradiographic axon-tracing.
    Beckstead RM
    Neuroscience; 1987 Feb; 20(2):557-76. PubMed ID: 2438592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axonal expression sites of tyrosine hydroxylase, calretinin- and calbindin-immunoreactivity in striato-pallidal and septal nuclei of the rat brain: a double-immunolabelling study.
    Seifert U; Härtig W; Grosche J; Brückner G; Riedel A; Brauer K
    Brain Res; 1998 Jun; 795(1-2):227-46. PubMed ID: 9622641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topographical distribution of substance P in the cat substantia nigra.
    Gauchy C; Beaujouan JC; Besson MJ; Kerdelhue B; Glowinski J; Michelot R
    Neurosci Lett; 1979 Apr; 12(1):127-31. PubMed ID: 460695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of substance P and enkephalin-like immunoreactivity in the substantia nigra of rat, cat and monkey.
    Inagaki S; Parent A
    Brain Res Bull; 1984 Aug; 13(2):319-29. PubMed ID: 6208980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcineurin immunoreactivity in striatonigral degeneration.
    Goto S; Hirano A; Rojas-Corona RR
    Acta Neuropathol; 1989; 78(1):65-71. PubMed ID: 2544073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forebrain projections from cholecystokininlike-immunoreactive neurons in the rat midbrain.
    Seroogy KB; Fallon JH
    J Comp Neurol; 1989 Jan; 279(3):415-35. PubMed ID: 2918078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence of heat shock response in deafferented neurons in the substantia nigra of rats.
    Yamada K; Goto S; Ushio Y
    Neuroscience; 1994 Oct; 62(3):793-801. PubMed ID: 7870307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.